Wrist Device, Medical Software Web Claims Draw Warning Letters
This article was originally published in The Gray Sheet
Carpal Kinetics' Wristrac for treatment of Carpal Tunnel Syndrome requires a 510(k) because the device differs from other nonpowered orthopedic traction devices, FDA informs the firm in a warning letter released Oct. 26
You may also be interested in...
Tecan is taking steps to bolster its regulatory processes, following compliance problems that emerged during an FDA inspection of the firm's Durham, N.C. facility
The WHO’s new "living guideline" against remdesivir’s use in hospitalized patients notwithstanding, some key opinion leaders in India see a role for the antiviral, but underscore that COVID-19 is still in its infancy and all repurposed therapies for the disease still have a long way to go. They also see the US remdesivir studies as more robust.
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.